Decoupling Neuroprotection from MAO Inhibition via Indane-to-Azaindane Bioisosteric Replacement of Rasagiline
Open Access
- 12 September 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (10) , 2251-2259
Abstract
Rasagiline is a monoamine oxidase B (MAO-B) inhibitor with neuroprotective effects, whose dependence on MAO-B inhibition remains unclear. Here, indane-to-azaindane rasagiline isosteres (rac-2a and rac-2b) were developed to investigate whether neuroprotection can be decoupled from MAO-B inhibition. Direct regioselective oxidation of 4-azaindane catalyzed by Mn(OAc)2/tBuOOH afforded the key 4-azaindan-1-one intermediate (6a). In paraquat-insulted dopaminergic differentiated SH-SY5Y cells, both analogs showed neuroprotection at 10 and 100 μM, with rac-2b outperforming rasagiline. The azaindane analogs displayed markedly reduced MAO-B inhibition and no time-dependent inhibition. These findings demonstrate that rasagiline neuroprotection can be dissociated from MAO-B inhibition, supporting azaindane bioisosterism for exploring MAO-independent neuroprotection.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (2020.02311.CEECIND/CP1596/CT0004)
- Fundação para a Ciência e a Tecnologia (2022.01175.PTDC)
- Fundação para a Ciência e a Tecnologia (2023.14440.PEX)
- Fundação para a Ciência e a Tecnologia (2024.02245.BD)
- Fundação para a Ciência e a Tecnologia (LA/P/0140/2020)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/147463/2019)
- Fundação para a Ciência e a Tecnologia (UI/BD/154888/2023)
- Fundação para a Ciência e a Tecnologia (UID/50006/2025)
- Fundação para a Ciência e a Tecnologia (UIDB/04378/2020)
- Fundação para a Ciência e a Tecnologia (UIDP/04378/2020)
- The Slovenian Research and Innovation Agency (P1-0208)
- European Regional Development Fund (COMPETE2030-FEDER-00881500)
- Rede de Química e Tecnologia (REQUIMTE 2025-42)
- Rede de Química e Tecnologia (REQUIMTE 2025-43)
This publication has 58 references indexed in Scilit:
- Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson’s disease: a systematic reviewNeurological Sciences, 2019
- Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotectionJournal of Neural Transmission, 2015
- The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrationsArchives of Toxicology, 2013
- Synthesis and evaluation of a series of aminocyanopyridines as antimicrobial agentsMedicinal Chemistry Research, 2009
- Monoamine oxidase inactivation: From pathophysiology to therapeuticsAdvanced Drug Delivery Reviews, 2008
- Paraquat-induced Neurodegeneration: a Model of Parkinson's Disease Risk Factors2008
- Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transitionJournal of Neuroscience Research, 2004
- Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV10222000
- (R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B1998
- Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP1990